Ziemer Ophthalmic Systems
Ziemer Ophthalmic Systems AG is a privately held Swiss medical device company that designs and sells femtosecond laser systems, diagnostic platforms, and workflow software for refractive, cataract, and therapeutic ophthalmic surgery, serving eye care professionals, hospitals, and clinics globally.
- Company typePrivate
- Founded1998
- HeadquartersBellmund, Switzerland
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ziemer Ophthalmic Systems does
Ziemer Ophthalmic Systems AG is a privately held Swiss medical device company founded in 1998 that designs, manufactures, and sells high-end femtosecond laser systems and diagnostic platforms for ophthalmic surgery. The company's core technology centers on a proprietary low-energy femtosecond laser concept operating in the MHz repetition rate range, which the company positions as differentiated from higher-energy competitors by enabling smoother stromal beds, reduced tissue damage, and faster visual recovery. Its product portfolio spans laser systems (FEMTO Z8 NEO, FEMTO LDV Z8, Z6, Z4, AQUARIUZ wet ablation platform), diagnostic devices (GALILEI G4, G6), and workflow software (FlowSuite), supporting refractive surgery (Z-LASIK, CLEAR Supra, AQUA LASIK/PRK), cataract surgery (CLARIGS), and therapeutic ophthalmic procedures including pediatric cataract surgery — an application for which Ziemer holds the only CE-marked femtosecond laser indication.
The company sells capital equipment directly to eye care professionals, hospitals, and clinics through wholly-owned regional subsidiaries in Switzerland (HQ), the United States, Germany, and China, complemented by a global distributor network for additional geographies. Revenue is generated primarily through hardware sales of laser and diagnostic systems, with recurring service/support contracts and FlowSuite software licenses providing secondary, ongoing streams. Pricing is not publicly disclosed, consistent with enterprise field sales to clinical buyers. Ziemer invests in clinical evidence generation, peer-reviewed publications, and major ophthalmology congresses (ESCRS, satellite symposiums) as core go-to-market channels, reflecting the clinical-evidence-driven adoption model typical of premium surgical capital equipment.
Founded and still led by Frank Ziemer as founder, president, and CEO, the company operates with an estimated 51–100 employees and reports no parent company, public listing, or external venture or private equity funding rounds. Recent activity in 2025 includes the launch of Z8 Platforms for pediatric cataract surgery, a new patient education website (ziemerpatients.com), and satellite symposium presence at ESCRS 2025 in Copenhagen, indicating active product and brand investment despite no disclosed financial transactions.
Ziemer Ophthalmic Systems firmographics
Firmographics- Name
- Ziemer Ophthalmic Systems
- Legal name
- Ziemer Ophthalmic Systems AG
- Website
- https://ziemergroup.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Ziemer Ophthalmic Systems AG is a privately held Swiss medical device company that designs and sells femtosecond laser systems, diagnostic platforms, and workflow software for refractive, cataract, and therapeutic ophthalmic surgery, serving eye care professionals, hospitals, and clinics globally.
- Ownership category
- akta.pro rank
Ziemer Ophthalmic Systems industry classification
Industry- Product category
- Ophthalmic Surgical Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)
- akta.pro secondary industry
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
Keywords
Where Ziemer Ophthalmic Systems is headquartered
LocationHeadquarters
- HQ city
- Bellmund
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Ziemer Ophthalmic Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Laser Systems Sales: Sale of femtosecond laser platforms including FEMTO Z8 NEO, FEMTO LDV Z8, FEMTO LDV Z6, FEMTO LDV Z4, and AQUARIUZ wet ablation laser to eye care professionals, hospitals, and clinics.
- Diagnostic Device Sales: Sale of diagnostic devices including GALILEI G4 and GALILEI G6 platforms for ophthalmic diagnostics and surgical planning.
- Service and Support Contracts: Ongoing support, maintenance, and service contracts for installed base of laser and diagnostic systems.
- Planning Software Licenses: Licensing of FlowSuite planning software and other software solutions for surgical planning and workflow management.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Ziemer Ophthalmic Systems product offering
Product offeringCore offering
Ziemer Ophthalmic Systems AG designs, manufactures, and sells high-end femtosecond laser platforms (FEMTO Z8 NEO, FEMTO LDV Z8/Z6/Z4), wet ablation laser systems (AQUARIUZ), diagnostic devices (GALILEI G4, GALILEI G6), and surgical planning software (FlowSuite) for ophthalmic surgeons performing refractive, cataract, and therapeutic eye surgery.
Product overview
Ziemer Ophthalmic Systems is a Swiss company specializing in high-end ophthalmic lasers, diagnostic devices, and customized surgical solutions for eye care professionals. The portfolio centers on femtosecond laser platforms (FEMTO Z8 NEO, FEMTO LDV Z8/Z6/Z4) with proprietary low energy technology operating in the MHz repetition rate range. The AQUARIUZ wet ablation laser platform enables scentless, gentle refractive procedures. Diagnostic devices (GALILEI G4, G6) integrate with planning software (FlowSuite) for seamless surgical workflow. The company serves three main treatment areas: Refractive surgery (Z-LASIK, AQUA LASIK/PRK, CLEAR Supra), Cataract surgery (CLARIGS), and Therapeutic applications, positioning Ziemer as a comprehensive surgical ecosystem rather than isolated products.
Differentiator
Problem solved
Functional benefit
Brands
- CLARIGS: Cataract Laser Advanced Robotic Image-Guided Surgery - an innovative system for cataract surgery combining Swiss engineering, low energy laser technology, and compact design with intra-operative OCT imaging.
- Z-LASIK
- CLEAR Supra
- AQUA Treatments
- AQUARIUZ
- FEMTO Z8 NEO
- FlowSuite
- GALILEI
Products and services
- FEMTO Z8 NEO Multipurpose femtosecond laser platform for refractive, therapeutic, and cataract surgery, featuring seamless workflow integration with any excimer laser on the market and intraoperative OCT imaging. Sold to eye care professionals, hospitals, and clinics.
- FEMTO LDV Z8 Femtosecond laser platform with low energy concept for precise tissue interaction and minimal side effects, supporting refractive and cataract surgery applications.
- FEMTO LDV Z6 Femtosecond laser system offering Ziemer's low energy technology for refractive surgery applications.
- FEMTO LDV Z4 Entry-level femtosecond laser platform with Ziemer's proprietary low energy concept for corneal surgery.
- AQUARIUZ Wet ablation laser platform enabling scentless and efficient refractive surgery with AQUA LASIK and AQUA PRK procedures, featuring innovative Wet Ablation Technology that maintains naturally hydrated cornea treatment.
- GALILEI G4 Holistic diagnostic platform for corneal mapping and analysis, integrated with Ziemer's surgical workflow.
- GALILEI G6 Advanced diagnostic platform building on GALILEI technology for comprehensive eye diagnostics.
- FlowSuite Planning software that streamlines surgical workflow by connecting diagnostic and surgical laser devices into a unified ecosystem, minimizing human-derived errors.
Quantifiable outcome
- Only 0.28% intraoperative complications across >1,800 eyes (0.17% anterior tears, 0.11% PCR) in FLACS procedures
- +3 more outcomes
Companies that use Ziemer Ophthalmic Systems
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
Ziemer Ophthalmic Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Ziemer Ophthalmic Systems partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Ziemer Ophthalmic Systems competitors and assessment
Company assessmentBroad incumbents
- Carl Zeiss Meditec: Markets the VisuMax femtosecond laser platform for refractive surgery (including SMILE lenticule extraction) and a wide ophthalmic surgical microscope/diagnostic portfolio, overlapping with Ziemer's FEMTO Z8 and GALILEI diagnostics in refractive and cataract workflows.
- Topcon Healthcare: Major ophthalmic diagnostic and imaging company whose anterior segment and surgical planning technologies intersect with Ziemer's GALILEI and FlowSuite platforms, particularly in refractive surgery planning workflows.
- NIDEK: Japanese ophthalmic equipment manufacturer with broad portfolio of refractive lasers, diagnostic devices, and cataract surgery systems that overlap with Ziemer's FEMTO, GALILEI, and AQUARIUZ product families.
- Alcon: Global leader in eye care with a portfolio that includes the LensX/Lensar femtosecond cataract laser platforms and WaveLight refractive excimer systems, directly competing with Ziemer's FEMTO and CLARIGS offerings across refractive and cataract surgery.
- Johnson & Johnson Vision: Operates the iFS Advanced Femtosecond Laser (originally IntraLase) for LASIK flap creation and a broad cataract IOL portfolio, competing head-to-head with Ziemer's FEMTO Z8 and CLARIGS in both refractive and cataract surgery markets.
- Bausch + Lomb: Sells the Victus femtosecond laser platform for cataract and refractive surgery along with a broad IOL and pharmaceutical ophthalmology portfolio, directly competing with Ziemer's CLARIGS cataract and FEMTO refractive platforms.
Direct peers
- LENSAR: U.S.-listed pure-play in femtosecond laser cataract surgery (ALLY system), directly competing with Ziemer's CLARIGS platform in the FLACS market with a focus on image-guided cataract workflows.
- SCHWIND eye-tech-solutions: German manufacturer of excimer lasers (AMARIS) for refractive surgery and adjacent diagnostic devices, competing with Ziemer's refractive laser and AQUARIUZ platforms particularly in the European refractive surgery market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Ziemer Ophthalmic Systems social profiles
Digital presenceZiemer Ophthalmic Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ziemer Ophthalmic Systems leadership team
Management profileNumber of profiles
Profiles1 record
Ziemer Ophthalmic Systems subsidiaries and ownership
Company hierarchySubsidiaries4 records
Ziemer Ophthalmic Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ziemer Ophthalmic Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ziemer Ophthalmic Systems
What does Ziemer Ophthalmic Systems do?
Ziemer Ophthalmic Systems AG designs, manufactures, and sells high-end femtosecond laser platforms (FEMTO Z8 NEO, FEMTO LDV Z8/Z6/Z4), wet ablation laser systems (AQUARIUZ), diagnostic devices (GALILEI G4, GALILEI G6), and surgical planning software (FlowSuite) for ophthalmic surgeons performing refractive, cataract, and therapeutic eye surgery.
Is Ziemer Ophthalmic Systems a public or private company?
Ziemer Ophthalmic Systems is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ziemer Ophthalmic Systems founded?
Ziemer Ophthalmic Systems was founded in 1998. It employs 51 to 100 people.
Where is Ziemer Ophthalmic Systems based?
Ziemer Ophthalmic Systems is headquartered in Bellmund, Switzerland, in the Europe region.
How does Ziemer Ophthalmic Systems make money?
Four revenue lines are on record. Laser Systems Sales are the primary driver. The others are diagnostic Device Sales, service and Support Contracts and planning Software Licenses.
Who are Ziemer Ophthalmic Systems's main competitors?
Broad incumbents on record are Carl Zeiss Meditec, Topcon Healthcare, NIDEK, Alcon, Johnson & Johnson Vision and Bausch + Lomb. Direct peers are LENSAR and SCHWIND eye-tech-solutions.
Does Ziemer Ophthalmic Systems have an API?
No public API is recorded for Ziemer Ophthalmic Systems.
What industry is Ziemer Ophthalmic Systems in?
Ziemer Ophthalmic Systems's product category is Ophthalmic Surgical Equipment. Its primary akta.pro industry code is HLAHAJAG, Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance), with a secondary code of HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 334510 and its SIC code is 3841.